Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
Geertje van der Horst(Leiden University Medical Center), Ellen C. Zwarthoff(Erasmus MC), Gabri van der Pluijm(Leiden University Medical Center), George N. Thalmann(University Hospital of Bern), Eline A. M. Ruigrok(Erasmus MC), Marianna Kruithof‐de Julio(University of Bern), Emily M. Ploeg(University Medical Center Groningen), Maaike H. van der Mark(Leiden University Medical Center), Joost L. Boormans(Erasmus MC), Rob C.M. Pelger(Leiden University Medical Center), Siri Tvingsholm(Danish Cancer Society), Arjanneke F. van de Merbel(Leiden University Medical Center), Marja Jäätelä(Danish Cancer Society), Chris H. Bangma(Erasmus MC), Janneke van Uhm(Leiden University Medical Center), L. M. Appelman(Leiden University Medical Center)
Cited by 15
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493